InnoStudio Inc. is a prominent leader in the development of innovative pharmaceutical formulations. Established to bridge the gap between scientific research and industry applications, the company employs proprietary technologies, most notably the ContiFlow® Technology Platform, to provide transformative solutions in drug delivery and advanced formulations. With state-of-the-art laboratories and a dedicated team of experts, InnoStudio is committed to driving progress in both sustainability and healthcare innovation.
ThalesNano Inc. is a global leader in continuous-flow chemistry
and process intensification, with over two decades of expertise in scalable chemical synthesis and AI-driven reaction optimization. With 20+ years on the market, ThalesNano has established itself as a modular flow reactor technology pioneer, enabling safe, efficient, and on-demand chemical production across pharmaceuticals and agrochemicals. Its AI-enhanced, modular production systems are redefining precision-driven active ingredient manufacturing, supporting the future of sustainable and scalable drug production.